Skip to main content

Table 2 Overall toxicity from chemotherapy in selected cohort.

From: Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients – analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO

Variable

Category

Number (%)

  

N = 664

Anaemia stage

0

116 (17.5)

 

1

241 (36.3)

 

2

259 (39.0)

 

3

39 (5.9)

 

4

9 (1.4)

Leucopenia stage

0

171 (25.8)

 

1

70 (10.5)

 

2

96 (14.5)

 

3

154 (23.2)

 

4

173 (26.1)

Thrombocytopenia

0

503 (75.8)

 

1

51 (7.7)

 

2

45 (6.8)

 

3

33 (5.0)

 

4

32 (4.8)

Mucositis

0

347 (52.3)

 

1

137 (20.6)

 

2

98 (14.8)

 

3

17 (2.6)

 

4

3 (0.5)

 

No data

62 (9.3)

Nausea/vomiting

0

329 (49.5)

 

1

168 (25.3)

 

2

68 (10.2)

 

3

39 (5.9)

 

4

5 (0.8)

 

No data

55 (8.3)

Diarrhoea

0

434 (65.4)

 

1

74 (11.1)

 

2

50 (7.5)

 

3

45 (6.8)

 

4

7 (1.1)

 

No data

54 (8.1)

Neuropathy

0

318 (47.9)

 

1

192 (28.9)

 

2

77 (11.6)

 

3

26 (3.9)

 

4

0

 

No data

51 (7.7)

Skin rash

0

521 (78.5)

 

1

50 (7.5)

 

2

27 (4.1)

 

3

7 (1.1)

 

4

2 (0.3)

 

No data

57 (8.6)